4//SEC Filing
McNaughton Thomas 4
Accession 0001144204-19-031336
CIK 0001563665other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 5:01 PM ET
Size
5.3 KB
Accession
0001144204-19-031336
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
McNaughton Thomas
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2019-06-14+35,000→ 35,000 totalExercise: $2.55From: 2019-06-14Exp: 2022-06-14→ Common Stock, par value $0.01 per share (35,000 underlying)
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeother
Related Parties
1- filerCIK 0001449450
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 5:01 PM ET
- Size
- 5.3 KB